According to The Insight Partners, “Global Helicobacter Pylori (H. pylori) Non-Invasive Testing Market Size, Share, Growth, Trends and Global Forecasts to 2028 – COVID-19 Impact and Global Analysis By Test Type (Serology, Stool Antigen, and Urea Breath), Test Method (Laboratory Based and Point-of-Care), and End User (Hospitals, Clinics, and Diagnostic Laboratories)”; the global helicobacter pylori (H. pylori) non-invasive testing market size is estimated to grow at a CAGR of 4.4% from 2022 to 2028, it is expected to grow from US$ 596.82 million in 2021 to US$ 800.04 million by 2028.
Download PDF Brochure at https://www.theinsightpartners.com/sample/TIPRE00005185
Need for Non-invasive Tests due to Rise in H. pylori Infection Cases
The rise in prevalence of H. pylori is one of the major reasons driving the Helicobacter Pylori (H. pylori) non-invasive testing market growth. Further, studies have shown that ~50% of the world’s population is infected by H. pylori infection. The Infection is usually developed during infancy but remains asymptomatic, with long-standing clinical symptoms including gastritis, peptic ulcer disease, and stomach cancer. Furthermore, the prevalence of the gastric disease is significantly higher in the geriatric population as aging increases the risk of H. pylori infection. According to World Health Organization (WHO), the population percentage aged 60 years and above is expected to be 13.7% globally and 20.3% in the south-east Asia region by 2030. Aging leads to thinning of the stomach lining, thus allowing the bacteria to pass through the protective lining that contributes to the growing prevalence of Infection among older people.
DiaSorin S.p.A.; Meridian Bioscience, Inc.; Exalenz Bioscience Ltd.; Alere; Thermo Fisher Scientific; Biomerica, Inc; Abbott; and CerTest Biotec are among the leading companies operating in the global Helicobacter Pylori (H. pylori) non-invasive testing market.
Check Exclusive Discount on this Report at https://www.theinsightpartners.com/discount/TIPRE00005185
Helicobacter Pylori (H. pylori) is a bacterial infection that is majorly detected in patients suffering from gastric and duodenal ulcers. For instance, the Centers for Disease Control and Infection (CDC) report states that the prevalence of H. pylori infection worldwide is ~50% and ~80-90% in developing countries. Moreover, the prevalence of H. pylori is estimated to be 35-40% in the US. The high prevalence of H. pylori infection positively influences the adoption of non-invasive diagnostic solutions. Technological advancements and innovations in the H. pylori non-invasive testing solutions offer accurate results and greater patient satisfaction among patients suffering from bacterial infection. For example, point-of-care testing (POCT) provides accurate results at an affordable price in a short time. As people with multiple health conditions are usually more vulnerable to infections and seek early detection of H. pylori infection, greater accessibility of POCT and easy availability of numerous invasive and non-invasive devices positively impact the market growth. For instance, in May 2022, Biomerica, Inc. announced a new product launch for the CE mark for its “hp+detect'” diagnostic test responsible for detecting H. pylori bacteria. The new product “hp+detect” product is responsible for detecting H. pylori bacteria, having a prevalence of 35% among the US population and 45% of Europe’s five largest countries.
Purchase Premium Copy of Helicobacter Pylori (H. pylori) Non-Invasive Testing Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00005185
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
Press Release: https://www.theinsightpartners.com/pr/helicobacter-pylori-h-pylori-non-invasive-testing-market